Updates on therapeutic development, commercial strategy, drug launches, manufacturing, safety insights, and lifecycle management across the pharmaceutical industry.
The shift from intravenous to subcutaneous drug administration is accelerating across oncology and immunology, fundamentally changing how patients receive treatment and how healthcare systems manage
Merck just scored FDA approval for Keytruda QLEX, a subcutaneous formulation of pembrolizumab that can be administered in 1-2 minutes instead of a 30-minute IV
The obesity drug market is heating up fast, and Pfizer just made a major play. Their acquisition of Metsera for up to $7.3 billion shows
AbbVie just pulled off one of the most successful patent defense strategies in recent pharmaceutical history. By settling with all generic challengers to its blockbuster
In a dramatic reversal that highlights the delicate balance of vaccine development, the FDA has suspended use of the world’s first chikungunya vaccine after recipients
The UK’s National Institute for Health and Care Excellence (NICE) has proposed the most significant overhaul of type 2 diabetes treatment in over a decade,
In a landmark decision that could transform treatment for hundreds of thousands of Americans, the FDA has approved Brinsupri (insmedpirdine) as the first-ever medication specifically
Korean biotech successfully launches on Korea Exchange with focus on once-monthly injectable treatments including Alzheimer’s candidate G2Gbio completed its public market debut on the Korea
Revolutionary needle-free epinephrine achieves $15.7M quarterly revenue with accelerating market adoption ARS Pharmaceuticals delivered exceptional Q2 2025 results with $15.7 million in total revenue, including
Senior credit facility supports Afrezza pediatric launch, commercial expansion, and pipeline advancement MannKind Corporation secured up to $500 million in a senior credit facility from
